Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2021-05-11, Stock:PFE, The news for the past five days is as follows:
2021-05-04: NEWS1: Pfizer: Anticipated Growth at a Fair Value.NEWS2: UPDATE 1-People aged over 50 in Britain to be offered 3rd COVID vaccine shot in autumn -The Times.NEWS3: Vaccine Sales Lift Pfizer’s Quarterly Results.NEWS4: Pfizer (PFE) Gains As Market Dips: What You Should Know.NEWS5: India Deaths May Double; Seychelles Cases Surge: Virus Update.NEWS6: What happened in the stock market today? Tech sees worst day since March, Dow ekes out gain.NEWS7: Pfizer Stock Eyes Breakout On Call For $26 Billion In Covid Vaccine Sales.NEWS8: CVS banks on future gains from pediatric vaccines as hesitant adults drive recent COVID vaccination decline.NEWS9: Dow manages to end up, but tech shares see worst one day fall since March.NEWS10: Pfizer Covid Vaccine Set to Become Highest-Selling Medication Ever.NEWS11: Pfizer in talks with India for COVID-19 vaccine.NEWS12: CVS Says Covid-19 Vaccinations Slow as U.S. Rollout Runs Into Hesitancy.NEWS13: How businesses are tracking their employee's vaccination status and well-being amid COVID-19 recovery.NEWS14: Pfizer’s next play: A vaccine maker and pandemic ‘partner’ to governments.NEWS15: Pfizer’s next play: A vaccine maker and pandemic ‘partner’ to governments.NEWS16: Pfizer CEO: 'We do think our stock is undervalued'.NEWS17: 'We’re entering the harder phase' of coronavirus vaccination.NEWS18: Biden aims to have 70% of U.S. adults receive first vaccine shot by July 4th.NEWS19: India’s COVID-19 case tally tops 20 million after nearly doubling in three months.NEWS20: Dow slides, Nasdaq tumbles 2.6% as fears of Fed tapering put investors on edge.NEWS21: Returning to normal ‘doesn’t have to be the goal’ amid COVID-19 recovery: Doctor.NEWS22: Pfizer Sees $26 Billion From Covid Shot, Big Potential Ahead.NEWS23: CVS banks on future gains from pediatric vaccines as hesitant adults drive recent COVID vaccination decline.NEWS24: Pfizer's BCMA/CD3 Bispecific Candidate Study Derailed Amid Safety Woes.NEWS25: S&P 500 Falls After Yellen Triggers Rate Hike Jitters.NEWS26: Stock Market Today With Jim Cramer: Why It's Time to Buy Pfizer Stock.NEWS27: Stocks End Mixed as Tech Tumbles and Yellen Raises Rate Fears.NEWS28: Pfizer (PFE) Q1 Earnings Beat, COVID-19 Vaccine Boosts Sales.NEWS29: Why BioNTech Stock Is Sinking Today.NEWS30: Pfizer’s Covid-19 Vaccine Could Be Approved for 12- to 15-Year-Olds By Next Week.NEWS31: Pfizer Reports Better-Than-Expected 1Q Results, Lifts COVID-19 Vaccine Sales Outlook.NEWS32: Pfizer Knocks It Out of the Park With Its Q1 Results.NEWS33: S&P 500 Slips on Tech Wreck as Yellen Stokes Inflation Jitters.NEWS34: India’s COVID-19 case tally tops 20 million after nearly doubling in three months.NEWS35: Dow down 280 points, with tech shares under heavy pressure.NEWS36: Pfizer, UnderArmour Beat; Trade Deficit at All-Time Low.NEWS37: Pfizer’s Vaccine Drove a Big Earnings Beat. What It Means for the Stock..NEWS38: Nasdaq Sinks as Tech Tumbles and Yellen Raises Rates Fears.NEWS39: Pfizer Posts Strong Earnings and Boosts Its Covid-19 Vaccine Sales Forecast. What You Need to Know..NEWS40: U.S. stocks dip in early trade, with tech shares under pressure.NEWS41: Pfizer posts earnings beat driven by COVID-19 revenue.NEWS42: Pfizer Is Gaining, CVS Is Jumping, and the Stock Market Is Slipping.NEWS43: Nasdaq Sinks 2.6% on Rotation Out of Tech, Yellen's Rates Comments.NEWS44: Pfizer sees robust COVID-19 vaccine demand for years, $26 billion in 2021 sales.NEWS45: Pfizer Earnings: What Happened with PFE.NEWS46: The Stock Market Is Slipping. Why Strong Earnings Aren’t Enough..NEWS47: Pfizer Beats Q1 Wall Street Estimates; Sees COVID-19 Vaccine Sales Of $26B In FY21.NEWS48: Zacks Industry Outlook Highlights: Johnson & Johnson, AstraZeneca and Pfizer.NEWS49: Pfizer (PFE) Q1 Earnings and Revenues Surpass Estimates.NEWS50: Pfizer Earnings Top, Guidance Raised On Coronavirus Vaccine; Stock Rises In Buy Zone.NEWS51: Dow set for muted action Tuesday as investors await Yellen remarks, parse earnings from CVS, Pfizer.NEWS52: Pfizer Inc. to Host Earnings Call.NEWS53: Nasdaq Sinks 2.5% on Rotation Out of Tech, Yellen's Rates Comments.NEWS54: Pfizer beats earnings expectations and lifts guidance, as COVID-19 revenue outlook increases 73%.NEWS55: Pfizer bets on COVID-19 vaccine demand for years, sees sales of $26 billion in 2021.NEWS56: UPDATE 5-Pfizer bets on COVID-19 vaccine demand for years, sees sales of $26 bln in 2021.NEWS57: PFIZER REPORTS STRONG FIRST-QUARTER 2021 RESULTS.NEWS58: Coronavirus tally: Global cases of COVID-19 top 153.5 million and India's death toll above 200,000.NEWS59: Travel stocks rally as EU prepares to open borders to vaccinated holidaymakers.NEWS60: Nasdaq Sinks as Investors Rotate Out of Tech Sector and Growth Shares.NEWS61: Vaxart Jumps on Positive Phase 1 Data for Oral COVID Vaccine.NEWS62: Premarket Movers Tuesday - Pfizer, CVS Health, Precipio.NEWS63: Pfizer Gains as FDA Set to Approve Vaccine for Early Teens.NEWS64: Welcome to the Show, Trading FedEx and UPS, Vaccine Cavalry, Pfizer's Moment?.NEWS65: UPDATE 1-South Africa allocates an extra $276 mln to fight COVID-19.NEWS66: Pfizer Beats Earnings Forecast, Sees $26 Billion In COVID Vaccine Sales.NEWS67: Reopening Trades, CO2 Record, Pfizer, Aramco Earnings - What's Moving Markets.NEWS68: Astellas' XTANDI™ (enzalutamide) Approved by European Commission for Men with Metastatic Hormone-Sensitive Prostate Cancer.NEWS69: Gates Divorce, Ethereum and Pfizer: 5 Things You Must Know Tuesday.NEWS70: Pfizer generates $3.5bn from Covid vaccine sales in the first quarter.NEWS71: US set to approve Pfizer Covid vaccine for 12- to 15-year-olds.NEWS72: BioNTech/Pfizer Covid vaccine to be approved for 12 to 15-year-olds.NEWS73: Pfizer COVID-19 vaccine expected to get FDA approval for kids 12-15 this week.
2021-05-05: NEWS1: Inside India's Serum Institute: The vaccine manufacturer at the heart of the world's COVID vaccine supply.NEWS2: U.S. Backs Waiver of Intellectual Property Protection for Covid-19 Vaccines.NEWS3: President Biden to back waiving IP protections for COVID vaccines.NEWS4: US talk of waiving vaccine patents is merely symbolic: Experts.NEWS5: Moderna Booster Effective; Canada May Mix Shots: Virus Update.NEWS6: Moderna releases new information on booster shots.NEWS7: White House supports waiving IP protections for COVID vaccines.NEWS8: Biden administration backs waiving IP protections for COVID vaccines.NEWS9: Single Shot Of AstraZeneca, Pfizer COVID-19 Vaccines Provide 87% Protection, South Korea Study Shows: Reuters.NEWS10: Global COVID-19 caseload at pandemic high for second straight week, says WHO.NEWS11: Pfizer's Hospira To Call Back Hospital Anesthetics Due To Mislabeling.NEWS12: Former Acting CDC Director on why it's 'really important' to pay attention to COVID-19 variants.NEWS13: Why BioNTech Stock Is Jumping Again Today.NEWS14: COVID SCIENCE-Sperm not impacted by Pfizer/BioNTech vaccine; neuropsychiatric symptoms persist in COVID-19 survivors.NEWS15: Pfizer Will Meet Growth Goals Even Without Vaccine Sales, CFO Says.NEWS16: Has Pfizer (PFE) Outpaced Other Medical Stocks This Year?.NEWS17: Investing in the Covid-19 vaccine companies? Here’s the great divide in the group.NEWS18: Global cases of COVID-19 stayed at highest levels since start of the pandemic in latest week, says WHO.NEWS19: Global cases of COVID-10 stayed at highest levels since start of the pandemic in latest week, says WHO.NEWS20: Canada authorizes Pfizer's COVID-19 vaccine for kids between the ages of 12 and 15 years old.NEWS21: CORRECTED-UPDATE 3-Canada allows Pfizer COVID-19 vaccine for children aged 12-15.NEWS22: Moderna Reports Earnings on Thursday. Here’s What to Expect..NEWS23: UPDATE 1-U.S. FDA expected to authorize Pfizer vaccine for 12-15-year-olds soon.NEWS24: Should Pfizer and Moderna Be Worried About This New COVID Vaccine Study?.NEWS25: Is Novavax Stock A Buy On Hints Its Covid Vaccine Is Nearing Authorization?.NEWS26: Can This News Push Ocugen Ahead of Pfizer and Moderna?.NEWS27: S.Korea says AstraZeneca, Pfizer COVID-19 vaccines 87% effective after first shot.NEWS28: Pfizer (PFE) Q1 2021 Earnings Call Transcript.NEWS29: The Top 10 Dividend Stocks to Buy in 2021.NEWS30: Canada approves first coronavirus vaccine for under-16s.
2021-05-06: NEWS1: Column: Biden's plan to waive vaccine patents is good news, but not enough to beat the pandemic.NEWS2: AFT president 'very bullish' on Biden Admin's school reopening efforts.NEWS3: If Pfizer's Vaccine Is a Winner, Why Did This Analyst Downgrade Its Stock?.NEWS4: Let drugmakers keep their Covid vaccine profits.NEWS5: India's COVID-19 cases soar with over 412,000 confirmed.NEWS6: Moderna’s first-ever profit and billion-dollar quarter is dampened by COVID-19 vaccine patent proposal.NEWS7: U.S. backing waiver of patent protection for vaccines is a ‘complex issue’: Doctor.NEWS8: Aerie's (AERI) Q1 Loss Wider Than Expected, Revenues Miss.NEWS9: Federal Judge Overturns National Ban on Evictions.NEWS10: COLUMN-Shifting sands of COVID-19 vaccine supply race give U.S. new advantage.NEWS11: Big Pharma Is Not the Tobacco Industry.NEWS12: Elizabeth Warren responds to Biden's backing of COVID-19 vaccine patent waivers: 'I'm delighted'.NEWS13: Pfizer Beat Earnings. But Here’s Why This Analyst Downgraded the Stock to Neutral..NEWS14: Moderna and Other Covid-19 Vaccine Stocks Are Sliding. The Reaction Might Be Overblown..NEWS15: U.S. Vaccine Patent Surprise Roils Pharma as WTO Debate Heats Up.NEWS16: Biden’s Vaccine Patent Move: Watch Out for Side Effects.NEWS17: Pfizer beat earnings but here’s why this analyst downgraded the stock to neutral.NEWS18: Moderna sees no impact on COVID-19 vaccine from potential patent waiver.NEWS19: UPDATE 1-Pfizer, BioNTech to provide COVID-19 vaccine to Olympic athletes.NEWS20: Pfizer and BioNTech to supply IOC with COVID-19 vaccines for Olympic and Paralympic Games athletes.NEWS21: Pfizer and BioNTech to Provide COVID-19 Vaccine Doses for Olympic Athletes at the 2020 Tokyo Games.NEWS22: Moderna, BioNTech Lead Losses on Vaccine IP Waivers.NEWS23: Vaxart Has 3 Advantages Over Pfizer and Moderna.NEWS24: Global pharma shares sink as Biden backs COVID-19 vaccine IP waiver.NEWS25: Pfizer Stock Looks Healthy At Current Levels.NEWS26: Dow Futures Higher After Jobless Claims; Pfizer Slumps on Patent Waiver.NEWS27: Premarket Movers Thursday - Moderna, Peloton, PayPal.NEWS28: Pfizer, Moderna Slump as Biden Supports COVID Vaccine Patent Waiver.NEWS29: Dow Futures Test New Record Highs; Pfizer, Moderna Slump on Patent Waiver.
2021-05-07: NEWS1: The Tussle Over Covid Vaccine Patents Looks Overblown. Why Moderna and BioNTech Can Weather the Jolts..NEWS2: Pfizer Lifts Covid-19 Vaccine Production Targets for 2021, 2022.NEWS3: AstraZeneca Weighs Seeking Full U.S. Approval for Covid Shot, Skipping Emergency-Use Application.NEWS4: Biotech ETFs to Suffer as US Backs IP Waiver for COVID-19 Vaccines.NEWS5: Vaccine Stocks Take Wild Ride Amid Political Clash, Earnings.NEWS6: Pfizer, BioNTech Seek Full FDA Approval For Covid Vaccine; Shares Pop.NEWS7: Moderna and Pfizer vaccines show defense against variants.NEWS8: EMA Safety Committee Reviews Heart Inflammation, Rare Nerve Disorder Reports After Pfizer, AstraZeneca COVID-19 Shots.NEWS9: Why BioNTech Stock Popped Today.NEWS10: Pfizer, BioNTech Ask FDA for Full Approval of Covid-19 Vaccine.NEWS11: The U.S. prepares to begin giving COVID-19 shots to 12- to 15-year-olds as Pfizer’s vaccine nears expanded authorization.NEWS12: ‘We are not out of the woods with this pandemic’: Doctor.NEWS13: Pfizer begins process of seeking full U.S. vaccine approval: RPT.NEWS14: What Would Full FDA Approval Mean for the Pfizer Vaccine?.NEWS15: U.S. CDC panel to vote on using Pfizer COVID-19 shot in adolescents.NEWS16: PFE vs. NVO: Which Stock Should Value Investors Buy Now?.NEWS17: Pfizer asks Swiss OK for COVID-19 vaccine for children 12 to 15.NEWS18: Corcept's (CORT) Q1 Earnings Miss Estimates, Revenues Fall Y/Y.NEWS19: UPDATE 3-Pfizer/BioNTech seek full U.S. OK of COVID-19 shot, target 4 bln doses in 2022.NEWS20: Pfizer-BioNTech start full U.S. approval application for COVID-19 vaccine.NEWS21: Pfizer First to Seek Full Approval for Covid-19 Vaccine in U.S..NEWS22: Pfizer and BioNTech Initiate Rolling Submission of Biologics License Application for U.S. FDA Approval of Their COVID-19 Vaccine.NEWS23: This May Be the Best News in Pfizer's Earnings Report.NEWS24: EU executive eyes new Pfizer deal for 1.8 bln COVID vaccines "very soon".NEWS25: Here Are the Best Healthcare Stocks That Robinhood Investors Love.NEWS26: The Best Robinhood Stocks to Buy With $300 Right Now.NEWS27: UPDATE 1-France delaying EU order for COVID-19 vaccine -Germany's Welt.NEWS28: Pfizer, BioNTech Submit COVID Vaccine for Full FDA Clearance.NEWS29: Unused COVID shots piling up in Japan amid slow rollout.NEWS30: UPDATE 1-Thailand expects up to 20 mln doses of Pfizer vaccine from July.NEWS31: U.S. move to loosen vaccine patents will draw drug companies to bargain: lawyers.NEWS32: France delaying EU order for COVID-19 vaccine -Germany's Welt.NEWS33: ICU Medical Inc (ICUI) Q1 2021 Earnings Call Transcript.NEWS34: Should children be vaccinated to slow the spread of coronavirus?.
2021-05-10: NEWS1: How This FDA Move Could Push Pfizer Stock Deeper Into A Winning Spree.NEWS2: The U.S. will begin giving COVID-19 shots to 12- to 15-year-olds as Pfizer’s vaccine gets expanded authorization.NEWS3: FDA authorizes emergency use of Pfizer, BioNTech COVID vaccine to kids 12-15.NEWS4: UPDATE 2-U.S. children ages 12 to 15 could begin COVID-19 vaccinations Thursday.NEWS5: U.S. authorizes Pfizer/BioNTech COVID vaccine for children 12 to 15.NEWS6: FDA Outlines Plan For Restarting Facility Inspections Halted Due To Pandemic.NEWS7: UK's NICE Provisionally Rejects Coverage Of Pfizer-Merck KGaA's Bavencio As First-Line Therapy For Bladder Cancer.NEWS8: COVID-19 is not at the point yet where we can have mass gatherings: Doctor.NEWS9: Dow Jones Rallies 300 Points To Extend Win Streak; Nasdaq Drops As Tech Stocks Weigh.NEWS10: It’s ‘very possible’ we will continue seasonal mask-wearing: UCLA Assistant Professor.NEWS11: BioNTech’s Covid-19 Vaccine Success Sparks Investments in German Biotech.NEWS12: EU won’t renew AstraZeneca COVID-19 vaccine; Pfizer shot will take precedence.NEWS13: UPDATE 1-One AZ COVID-19 vaccine dose gives 80% lower death risk - English data.NEWS14: What This REIT's Blockbuster Quarter Means for Life Sciences.NEWS15: India’s COVID crisis deepens, as BioNTech says there’s no evidence its vaccine needs adapting to cope with new variants.NEWS16: When Will Adolescents Be Eligible for a Coronavirus Vaccine?.NEWS17: What BioNTech’s Earnings Mean for the Drug Makers.NEWS18: Are Coronavirus Vaccine Boosters Inevitable?.NEWS19: BioNTech Delivers Blowout Q1 Results.NEWS20: UPDATE 1-BioNTech committed to deliver 1.8 bln doses of COVID-19 vaccine this year.NEWS21: EU Ditches AstraZeneca Vaccine. It’s Pivoting to Pfizer..NEWS22: BioNTech committed to deliver 1.8 bln doses of COVID-19 vaccine this year.NEWS23: Moderna's Vaccine Produces Antibodies for at Least 6 Months.NEWS24: 3 Robinhood Stocks With High Dividend Yields.NEWS25: BioNTech Rises on Revenue Jump Due to Sale of COVID Vaccine.NEWS26: BioNTech Pops On Strong Quarter, Plans To Make Covid Shots in Asia.NEWS27: 4 Top Healthcare Stocks to Buy Now.NEWS28: BioNTech powers to profit on Covid vaccine demand.

Answer: Decrease